Tectonic Therapeutic reported $17K in Loan Capital for its fiscal quarter ending in March of 2026.





Loan Capital Change Date
Akebia Therapeutics USD 12.78M 11.98M Sep/2026
Alnylam Pharmaceuticals USD 2.11B 358.58M Sep/2026
Celltrion KRW 412.88B 1.61B Jun/2026
Cspc Pharmaceutical CNY 180.69M 21.94M Dec/2025
Deva Holding AS TRY 559.97M 44.39M Sep/2023
Dianthus Therapeutics USD 0 0 Dec/2024
Divis Laboratories Ltd INR 40M 10M Sep/2026
Gilead Sciences USD 23.82B 17M Sep/2026
Ionis Pharmaceuticals USD 1.77B 140.62M Sep/2026
Kangmei Pharma CNY 67.35M 1.22M Jun/2026
Karyopharm Therapeutics USD 264.49M 13.73M Mar/2026
Knight Therapeutics CAD 57.78M 26.92M Dec/2025
Laboratorios Farma EUR 80.5M 28.26M Dec/2024
MacroGenics USD 163.16M 94.44M Jun/2026
Malin Corporation EUR 0 0 Dec/2024
Medical Developments International AUD 1.5M 167K Dec/2025
Organigram Holdings CAD 17.61M 43.15M Jun/2026
Ovoca Bio EUR 0 0 Jun/2021
Pfizer USD 60B 498M Sep/2026
Pharma Mar EUR 36.24M 4.11M Sep/2026
Qiagen NV USD 1.63B 19.45M Jun/2026
Roche Holding CHF 25.22B 2.21B Jun/2026
Sangamo BioSciences USD 0 0 Jun/2022
Sanofi EUR 16.28B 1.63B Sep/2026
Sarepta Therapeutics USD 699.39M 148.23M Sep/2026
Sartorius EUR 3.43B 216.6M Sep/2026
Sino Biopharmaceutical CNY 3.08B 1B Jun/2025
Takeda JPY 4.17T 245.32B Sep/2026
Tilray USD 268.59M 3.82M Sep/2025
Zealand Pharma A/S 307M 76.14M Mar/2026
Zz Pientze Pharmaceu CNY 160.45M 12.35M Sep/2026